Mary Kay, through its philanthropic organization the Mary Kay Ash Foundation, selected the Baylor Scott & White Dallas Foundation for a $500,000 grant to advance cancer research and early detection. The multi-year gift will support groundbreaking clinical trials and help shift cancer care from reactive to proactive.
The grant is two-fold and includes $100,000 to support the TRIM-EBC Clinical Trial that will examine the potential of weight loss medications to reduce recurrence risk in overweight breast cancer patients, as well as a multi-year gift to the Texas Cancer Interception Institute to revolutionize early detection and intervention strategies for better breast cancer survivorship.
“The Mary Kay Ash Foundation remains committed to finding cures for cancers affecting women—we are championing for our mothers, daughters, sisters and all the women in our lives,” said Michael Lunceford, President, Mary Kay Ash Foundation Board of Directors. “This grant represents a powerful next step in redefining cancer care—moving from a reactive nature to early detection and viable treatment options—with the goal of a long, healthy life after cancer. We are honored to stand alongside Baylor Scott & White in shaping the future of women’s health.”
The Mary Kay Ash Foundation is a long-time supporter of the Baylor Scott & White Dallas Foundation, giving $1.3 million to the organization over the past two decades. To recognize this commitment and partnership, the Mary Kay Ash Foundation was honored with the Circle of Care Awards at the 2025 Celebrating Women Luncheon, hosted by the Baylor Scott & White Dallas Foundation.
“Mary Kay Ash believed in the power of women to change the world—that conviction lives on through her namesake Foundation’s bold commitment to advancing women’s health by investing in early detection and better treatments,” said Christina Goodman, President, Baylor Scott & White Dallas Foundation. “When brilliant minds like Dr. Joyce O’Shaughnessy, MD and compassionate hearts come together, extraordinary things happen. This partnership is focused on bringing hope, healing and new possibilities to patients and families across our communities.”
